DEBRA research invests in Topadur to advance small-molecule therapies for dystrophic Epidermolysis bullosa

by rss feed | Oct 28, 2026 | News Feeds

DEBRA Research gGmbH, a global non-profit organization dedicated to advancing research and drug development for Epidermolysis bullosa (EB), and Topadur Pharma AG, a Swiss clinical-stage biopharmaceutical company, today announced an investment by DEBRA Research in...

Adalvo expands biosimilars portfolio through acquisition of romiplostim biosimilar program from Enzene

by rss feed | Oct 28, 2026 | News Feeds

Adalvo today announced the acquisition of a romiplostim biosimilar program referencing Nplate® from Enzene, strengthening its biosimilars portfolio and accelerating the company’s expansion into complex biological medicines. Read Original...

Alcami announces promotion of Robert Tragas to Vice President, Laboratory Services

by rss feed | Oct 28, 2026 | News Feeds

Alcami, a leading contract development and manufacturing organization (CDMO), today announced its strengthening of laboratory leadership with the promotion of Robert Tragas to Vice President, Laboratory Services. Read Original...

Prolific announces major new investments and partnerships with Nantworks and Zylidac Bio CDMO

by rss feed | Oct 28, 2026 | News Feeds

On the heels of our exciting major investment and Nantworks partnership announcement last week, Prolific Machines is pleased to announce a great new partnership with Zylidac Bio, a fully integrated biologics CDMO located next door to us in San Francisco Bay Area, to...

NIOX® launches NIOX PRO®, their next generation FeNO testing device

by rss feed | Oct 28, 2026 | News Feeds

NIOX Group plc, a global leader in fractional exhaled nitric oxide (FeNO) testing, has announced the launch of NIOX PRO®, its next-generation FeNO testing device designed to support healthcare professionals in the diagnosis and management of asthma, COPD and other...